Share
PDF
Other content recommended for you
- Does egg donation for mitochondrial replacement techniques generate parental responsibilities
- De novo mtDNA point mutations are common and have a low recurrence risk
- Should mitochondrial replacement therapy be funded by the National Health Service
- ‘ No ’ to lesbian motherhood using human nuclear genome transfer
- Ethics of modifying the mitochondrial genome
- Preimplantation genetic diagnosis in mitochondrial DNA disorders: challenge and success
- Analysis of mtDNA variant segregation during early human embryonic development: a tool for successful NARP preimplantation diagnosis
- Gender “ tailored ” conceptions: should the option of embryo gender selection be available to infertile couples undergoing assisted reproductive technology
- Ethics of mitochondrial gene replacement: from bench to bedside
- Prenatal screening and prenatal diagnosis: contemporary practices in light of the past